Montair 4 mg Chewable Tablet (15 Tab)

Cipla Ltd.(M)

Generic Name: Montelukast 4mg
PTR :

124.91

MRP* 163.95

(* Inclusive of all taxes)
4 mg Chewable Tablet
6%
Return Policy Exp Dt: May 2028

Medicine Information

About Montair 4 mg Tablet:

Each chewable Montair 4 mg tablet contains Montelukast Sodium equivalent to Montelukast 4 mg.

Montair 4 mg tablet is a leukotriene inhibitor. Leukotrienes are chemicals that the body releases when an allergen (such as pollen) was breathed in. These chemicals cause swelling in the lungs and tightening of the muscles around the airways, which can result in asthma symptoms. Montair 4 mg tablet binds with high affinity to the cysteinyl leukotriene type-1 (CysLT1) receptor and inhibits physiologic actions of LTD4 at the CysLT1 receptor without any agonist activity. Therefore it acts as a leukotriene receptor antagonist.

Use of Montair 4 mg Tablet:

Montair 4 mg tablet is prescribed for the prophylaxis and chronic treatment of asthma, to prevent exercise-induced bronchoconstriction, and to treat seasonal allergic rhinitis.

Usage direction of Montair 4 mg Tablet:

  • Montair 4 mg tablet should be taken orally, as advised by the physician.
  • Do not stop or skip the medicine without physician’s advice.
  • Do not consume more than the prescribed quantity.

Precaution & Related information of Montair 4 mg Tablet:

  • For paediatric use only.
  • If allergic to this medicine, inform the physician immediately.
  • If find any other complication inform the physician immediately.
  • Consult with the physician during pregnancy & lactation.
  • Keep out of reach of children.

Storage condition of Montair 4 mg Tablet:

Store below 25°C. Protect from light and moisture.